P67809 (YBOX1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 108.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nuclease-sensitive element-binding protein 1 Alternative name(s): CCAAT-binding transcription factor I subunit A Short name=CBF-A DNA-binding protein B Short name=DBPB Enhancer factor I subunit A Short name=EFI-A Y-box transcription factor Y-box-binding protein 1 Short name=YB-1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 324 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates pre-mRNA alternative splicing regulation. Binds to splice sites in pre-mRNA and regulates splice site selection. Binds and stabilizes cytoplasmic mRNA. Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors By similarity. Regulates the transcription of numerous genes. Its transcriptional activity on the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7'. Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes. Promotes separation of DNA strands that contain mismatches or are modified by cisplatin. Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA (in vitro). May play a role in DNA repair. Component of the CRD-mediated complex that promotes MYC mRNA stability. Binds preferentially to the 5'-[CU]CUGCG-3' motif in vitro. Ref.7 Ref.8 Ref.9 Ref.11 Ref.21 Ref.23 Ref.25 Ref.27 The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation. Ref.7 Ref.8 Ref.9 Ref.11 Ref.21 Ref.23 Ref.25 Ref.27 |
| Subunit structure | Identified in a histone pre-mRNA complex, at least composed of ERI1, LSM11, SLBP, SNRPB, SYNCRIP and YBX1 By similarity. Component of the coding region determinant (CRD)-mediated complex, composed of DHX9, HNRNPU, IGF2BP1, SYNCRIP and YBX1. Identified in a mRNP complex, at least composed of DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2, SYNCRIP and YBX1. Identified in a mRNP granule complex, at least composed of ACTB, ACTN4, DHX9, ERG, HNRNPA1, HNRNPA2B1, HNRNPAB, HNRNPD, HNRNPL, HNRNPR, HNRNPU, HSPA1, HSPA8, IGF2BP1, ILF2, ILF3, NCBP1, NCL, PABPC1, PABPC4, PABPN1, RPLP0, RPS3, RPS3A, RPS4X, RPS8, RPS9, SYNCRIP, TROVE2, YBX1 and untranslated mRNAs. Component of the U11/U12 snRNPs that are part of the U12-type spliceosome. Interacts with IGF2BP1 and RBBP6. Component of cytoplasmic messenger ribonucleoprotein particles (mRNPs). Interacts with AKT1, MBNL1, SFRS9, ALYREF/THOC4, MSH2, XRCC5, WRN and NCL. Can bind to DNA as a homomeric form, (EFI-A)n or as a heteromeric form in association with EFI-B. Homodimer in the presence of ATP. Interacts (via C-terminus) with APEX1 (via N-terminus); the interaction is increased with APEX1 acetylated at 'Lys-6' and 'Lys-7'. Interacts with EIF2C1 and EIF2C2. Ref.7 Ref.9 Ref.10 Ref.11 Ref.12 Ref.14 Ref.17 Ref.19 Ref.20 Ref.21 Ref.23 Ref.27 Ref.32 |
| Subcellular location | Cytoplasm. Nucleus. Cytoplasmic granule. Secreted. Note: Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles between nucleus and cytoplasm. Predominantly cytoplasmic in proliferating cells. Cytotoxic stress and DNA damage enhance translocation to the nucleus. Localized with DDX1, MBNL1 and TIAL1 in stress granules upon stress. Secreted by mesangial and monocytic cells after inflammatory challenges. Translocates from the cytoplasm to the nucleus after and colocalizes with APEX1 in nuclear speckles after genotoxic stress. Ref.9 Ref.11 Ref.14 Ref.19 Ref.21 Ref.25 Ref.27 |
| Post-translational modification | Ubiquitinated by RBBP6; leading to a decrease of YBX1 transcactivational ability. Ref.20 In the absence of phosphorylation the protein is retained in the cytoplasm. Cleaved by a 20S proteasomal protease in response to agents that damage DNA. Cleavage takes place in the absence of ubiquitination and ATP. The resulting N-terminal fragment accumulates in the nucleus By similarity. |
| Sequence similarities | Contains 1 CSD (cold-shock) domain. |
| Sequence caution | The sequence AAA35750.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence AAA59949.1 differs from that shown. Reason: Frameshift at several positions. The sequence AAA61308.1 differs from that shown. Reason: Frameshift at position 314. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CTCF | Q08705 | 2 | EBI-354065,EBI-932806 | From a different organism. |
| EP300 | Q09472 | 2 | EBI-354065,EBI-447295 | |
| HNRNPD | Q14103-4 | 3 | EBI-354065,EBI-432545 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||
Molecule processing | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.6 | |||||||||||||||||
| Chain | 2 – 324 | 323 | Nuclease-sensitive element-binding protein 1 | PRO_0000100219 | ||||||||||||||||
Regions | ||||||||||||||||||||
| Domain | 61 – 125 | 65 | CSD | |||||||||||||||||
| Region | 15 – 71 | 57 | Interaction with ss-DNA | |||||||||||||||||
Sites | ||||||||||||||||||||
| Site | 219 – 220 | 2 | Cleavage; by 20S proteasomal protease | |||||||||||||||||
Amino acid modifications | ||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylserine Ref.6 | |||||||||||||||||
| Modified residue | 102 | 1 | Phosphoserine; by PKB/AKT1 Ref.14 Ref.28 | |||||||||||||||||
| Modified residue | 162 | 1 | Phosphotyrosine Ref.13 | |||||||||||||||||
| Modified residue | 165 | 1 | Phosphoserine Ref.6 Ref.28 Ref.29 Ref.31 | |||||||||||||||||
| Modified residue | 167 | 1 | Phosphoserine Ref.28 Ref.29 Ref.31 | |||||||||||||||||
| Modified residue | 174 | 1 | Phosphoserine Ref.15 Ref.24 Ref.28 Ref.29 Ref.31 | |||||||||||||||||
| Modified residue | 176 | 1 | Phosphoserine Ref.15 Ref.24 Ref.28 Ref.29 Ref.31 | |||||||||||||||||
| Modified residue | 301 | 1 | N6-acetyllysine Ref.25 | |||||||||||||||||
| Modified residue | 304 | 1 | N6-acetyllysine Ref.25 | |||||||||||||||||
| Modified residue | 314 | 1 | Phosphoserine Ref.31 | |||||||||||||||||
| Cross-link | 137 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.22 | ||||||||||||||||||
Experimental info | ||||||||||||||||||||
| Mutagenesis | 102 | 1 | S → A: Loss of phosphorylation by PKB/AKT1. Inhibits translocation to the nucleus and tumor cell growth. Ref.14 | |||||||||||||||||
| Mutagenesis | 301 | 1 | K → A: Abrogates unconventional secretion. Ref.25 | |||||||||||||||||
| Mutagenesis | 304 | 1 | K → A: Abrogates unconventional secretion. Ref.25 | |||||||||||||||||
| Sequence conflict | 120 | 1 | A → E in AAA61308. Ref.2 | |||||||||||||||||
Secondary structure | ||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||
| Beta strand | 56 – 67 | 12 | ||||||||||||||||||
| Turn | 68 – 71 | 4 | ||||||||||||||||||
| Beta strand | 72 – 77 | 6 | ||||||||||||||||||
| Turn | 78 – 81 | 4 | ||||||||||||||||||
| Beta strand | 82 – 87 | 6 | ||||||||||||||||||
| Helix | 88 – 90 | 3 | ||||||||||||||||||
| Beta strand | 108 – 115 | 8 | ||||||||||||||||||
| Beta strand | 117 – 125 | 9 | ||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology." Sakura H., Maekawa T., Imamoto F., Yasuda K., Ishii S. Gene 73:499-507(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box." Didier D.K., Schiffenbauer J., Woulfe S.L., Zacheis M., Schwartz B.D. Proc. Natl. Acad. Sci. U.S.A. 85:7322-7326(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Full length cDNA sequence encoding a nuclease-sensitive element DNA binding protein." Kolluri R., Kinniburgh A.J. Nucleic Acids Res. 19:4771-4771(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | "A human protein containing a 'cold shock' domain binds specifically to H-DNA upstream from the human gamma-globin genes." Horwitz E.M., Maloney K.A., Ley T.J. J. Biol. Chem. 269:14130-14139(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Bone marrow. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Adrenal cortex, Eye, Kidney, Muscle, Placenta, Skin, Testis and Uterus. |
| [6] | Bienvenut W.V. Submitted (JAN-2010) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-53; 70-93; 102-137; 157-185; 205-231; 257-279 AND 305-324, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, PHOSPHORYLATION AT SER-165, MASS SPECTROMETRY. Tissue: Ovarian carcinoma. |
| [7] | "Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation." Chen C.-Y., Gherzi R., Andersen J.S., Gaietta G., Juerchott K., Royer H.-D., Mann M., Karin M. Genes Dev. 14:1236-1248(2000) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, SUBUNIT. |
| [8] | "Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA." Capowski E.E., Esnault S., Bhattacharya S., Malter J.S. J. Immunol. 167:5970-5976(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [9] | "Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection." Raffetseder U., Frye B., Rauen T., Juerchott K., Royer H.-D., Jansen P.L., Mertens P.R. J. Biol. Chem. 278:18241-18248(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SFRS9, SUBCELLULAR LOCATION. |
| [10] | "Regulation of alternative splicing by SRrp86 and its interacting proteins." Li J., Hawkins I.C., Harvey C.D., Jennings J.L., Link A.J., Patton J.G. Mol. Cell. Biol. 23:7437-7447(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SFRS12. |
| [11] | "YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins." Gaudreault I., Guay D., Lebel M. Nucleic Acids Res. 32:316-327(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, INTERACTION WITH ALYREF/THOC4; NCL; XRCC5; WRN AND MSH2. |
| [12] | "The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome." Will C.L., Schneider C., Hossbach M., Urlaub H., Rauhut R., Elbashir S., Tuschl T., Luehrmann R. RNA 10:929-941(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH THE U11/U12 SPLICEOSOME, MASS SPECTROMETRY. |
| [13] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-162, MASS SPECTROMETRY. |
| [14] | "Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells." Sutherland B.W., Kucab J., Wu J., Lee C., Cheang M.C.U., Yorida E., Turbin D., Dedhar S., Nelson C., Pollak M., Leighton Grimes H., Miller K., Badve S., Huntsman D., Blake-Gilks C., Chen M., Pallen C.J., Dunn S.E. Oncogene 24:4281-4292(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-102, INTERACTION WITH AKT1, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-102. |
| [15] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174 AND SER-176, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [17] | "Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells." Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M., Urlaub H., Meister G. EMBO Rep. 8:1052-1060(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EIF2C1 AND EIF2C2. |
| [18] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Prostate cancer. |
| [19] | "Molecular composition of IMP1 ribonucleoprotein granules." Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R., Johnsen A.H., Christiansen J., Nielsen F.C. Mol. Cell. Proteomics 6:798-811(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A MRNP GRANULE COMPLEX, INTERACTION WITH IGF2BP1, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY. |
| [20] | "RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1." Chibi M., Meyer M., Skepu A., Rees D.J.G., Moolman-Smook J.C., Pugh D.J. J. Mol. Biol. 384:908-916(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RBBP6, UBIQUITINATION. |
| [21] | "MBNL1 associates with YB-1 in cytoplasmic stress granules." Onishi H., Kino Y., Morita T., Futai E., Sasagawa N., Ishiura S. J. Neurosci. Res. 86:1994-2002(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MBNL1, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY. |
| [22] | "Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry." Meierhofer D., Wang X., Huang L., Kaiser P. J. Proteome Res. 7:4566-4576(2008) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-137, MASS SPECTROMETRY. |
| [23] | "Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1." Chattopadhyay R., Das S., Maiti A.K., Boldogh I., Xie J., Hazra T.K., Kohno K., Mitra S., Bhakat K.K. Mol. Cell. Biol. 28:7066-7080(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DNA-BINDING, INTERACTION WITH APEX1. |
| [24] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174 AND SER-176, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen." Frye B.C., Halfter S., Djudjaj S., Muehlenberg P., Weber S., Raffetseder U., En-Nia A., Knott H., Baron J.M., Dooley S., Bernhagen J., Mertens P.R. EMBO Rep. 10:783-789(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-301 AND LYS-304, ACETYLATION AT LYS-301 AND LYS-304. |
| [26] | "Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins." Ray D., Kazan H., Chan E.T., Pena Castillo L., Chaudhry S., Talukder S., Blencowe B.J., Morris Q., Hughes T.R. Nat. Biotechnol. 27:667-670(2009) [PubMed] [Europe PMC] [Abstract] Cited for: RNA-BINDING. |
| [27] | "Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs." Weidensdorfer D., Stoehr N., Baude A., Lederer M., Koehn M., Schierhorn A., Buchmeier S., Wahle E., Huettelmaiery S. RNA 15:104-115(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, COMPONENT OF THE CRD-MEDIATED MRNA STABILIZATION COMPLEX, IDENTIFICATION IN A MRNP COMPLEX, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY. |
| [28] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-165; SER-167; SER-174 AND SER-176, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [29] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165; SER-167; SER-174 AND SER-176, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [30] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [31] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165; SER-167; SER-174; SER-176 AND SER-314, MASS SPECTROMETRY. |
| [32] | "The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1." Kloks C.P.A.M., Spronk C.A.E.M., Lasonder E., Hoffmann A., Vuister G.W., Grzesiek S., Hilbers C.W. J. Mol. Biol. 316:317-326(2002) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 52-129, INTERACTION WITH SS-DNA. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M24070 mRNA. Translation: AAA35750.1. Different initiation. J03827 mRNA. Translation: AAA61308.1. Frameshift. M83234 mRNA. Translation: AAA59949.1. Frameshift. L28809 mRNA. Translation: AAA20871.1. BC002411 mRNA. Translation: AAH02411.1. BC010430 mRNA. Translation: AAH10430.1. BC015208 mRNA. Translation: AAH15208.1. BC038384 mRNA. Translation: AAH38384.1. BC065571 mRNA. Translation: AAH65571.1. BC070084 mRNA. Translation: AAH70084.1. BC071708 mRNA. Translation: AAH71708.1. BC090038 mRNA. Translation: AAH90038.1. BC098435 mRNA. Translation: AAH98435.1. BC106045 mRNA. Translation: AAI06046.1. | ||||||||||||
| IPI | IPI00031812. | ||||||||||||
| PIR | I39382. S34426. | ||||||||||||
| RefSeq | NP_004550.2. NM_004559.3. | ||||||||||||
| UniGene | Hs.473583. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P67809. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-29405N. | ||||||||||||
| IntAct | P67809. 115 interactions. | ||||||||||||
| MINT | MINT-5001202. | ||||||||||||
| STRING | 9606.ENSP00000361626. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P67809. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 54040031. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P67809. | ||||||||||||
| PRIDE | P67809. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 4904. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000321358; ENSP00000361626; ENSG00000065978. | ||||||||||||
| GeneID | 4904. | ||||||||||||
| KEGG | hsa:4904. | ||||||||||||
| UCSC | uc001chs.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 4904. | ||||||||||||
| GeneCards | GC01P043148. | ||||||||||||
| H-InvDB | HIX0037767. HIX0172381. | ||||||||||||
| HGNC | HGNC:8014. YBX1. | ||||||||||||
| HPA | CAB005875. HPA040304. | ||||||||||||
| MIM | 154030. gene. | ||||||||||||
| neXtProt | NX_P67809. | ||||||||||||
| PharmGKB | PA31791. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG1278. | ||||||||||||
| HOGENOM | HOG000116439. | ||||||||||||
| HOVERGEN | HBG008757. | ||||||||||||
| InParanoid | P67809. | ||||||||||||
| KO | K09276. | ||||||||||||
| OMA | VEGADNQ. | ||||||||||||
| OrthoDB | EOG46DM3W. | ||||||||||||
| PhylomeDB | P67809. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | ptp1bpathway. Signaling events mediated by PTP1B. | ||||||||||||
| Reactome | REACT_1675. mRNA Processing. REACT_71. Gene Expression. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P67809. | ||||||||||||
| Bgee | P67809. | ||||||||||||
| CleanEx | HS_YBX1. | ||||||||||||
| Genevestigator | P67809. | ||||||||||||
| GermOnline | ENSG00000065978. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.40.50.140. 1 hit. | ||||||||||||
| InterPro | IPR019844. Cold-shock_CS. IPR011129. Cold_shock_prot. IPR002059. CSP_DNA-bd. IPR012340. NA-bd_OB-fold. [Graphical view] | ||||||||||||
| Pfam | PF00313. CSD. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00050. COLDSHOCK. | ||||||||||||
| SMART | SM00357. CSP. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF50249. Nucleic_acid_OB. 1 hit. | ||||||||||||
| PROSITE | PS00352. COLD_SHOCK. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | P67809. | ||||||||||||
| GenomeRNAi | 4904. | ||||||||||||
| NextBio | 18871. | ||||||||||||
| PMAP-CutDB | P67809. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | YBOX1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P67809 Secondary accession number(s): P16990 Q5FVF0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
